Skip to main content
. Author manuscript; available in PMC: 2014 Sep 1.
Published in final edited form as: J Acquir Immune Defic Syndr. 2013 Sep 1;64(1):e1–e8. doi: 10.1097/QAI.0b013e31829b567d

Table 3.

Change in behavior and viral load from study enrollment to 6 month follow-up visit among HIV-infected persons identified through home-based counseling and testing (HBCT)

N Baseline^ Median (IQR) Month 6 Median (IQR) Change over 6 months p-value*
Behavior and uptake of care
Number of sex partners (#2) 196 1.0 (0.0–1.0) 0.0 (1.0–1.0) −0.08 0.03
N Baseline^
N (%)
Month 6
N (%)
Change over 6 months p-value*
Condom use during last sexual intercourse 186 81 (44) 127 (68) 25% <0.001
Clinic visit among HIV+
All 201 115 (57) 195 (97) 40% <0.001
  Aware of HIV+ status 128 108 (84) 125 (98) 13% <0.001
  Newly identified HIV+ 73 7 (10) 70 (96) 86% <0.001
ART use
All participants 201 64 (32) 99 (49) 17% <0.001
  Aware of HIV+ status 128 64 (50) 80 (63) 13% <0.001
   ART eligible (CD4≤200) 9 3 (33) 9 (100) 67% ***
  Newly identified HIV+ 73 0 (0) 19 (26) 26% ***
   ART eligible (CD4≤200) 9 0 (0) 6 (67) 67% ***
HIV viral load Mean HIV viral load (log10 copies/mL)
N Baseline^viral load Month 6 viral load Change over 6 months p-value*
All HIV+ 196 2.92 2.64 −0.28 0.02
HIV+ not on ART at baseline 132 3.74 3.30 −0.44 0.007
HIV+ on ART at baseline 64 1.24 1.30 0.06 0.624
CD4 ≤200 (excluding HIV+ on ART at baseline) 12 4.93 1.70 −3.23 <0.001
CD4 201–≤350 (excluding HIV+ on ART at baseline) 31 3.77 3.40 −0.36 0.29
Change in percent with viral suppression (<1,000 c/mL) from baseline to 6 months (%)
All HIV+ 196 50% 55% 5% 0.21
HIV+ with CD4 ≤200 15 20% 80% 60% 0.01
HIV+ with CD4 ≤201–≤350 47 51% 57% 6% 0.55
^

Baseline visit is the first HBCT vist at study enrollment.

*

McNemar’s test was used to calculate p-value for binary outcome and paired t-test was used to calculate p-value for continuous outcome.

**

Three participants died and 2 withdrew from the study and were excluded from the follow-up analysis.

***

Cannot compute McNemar’s p-value due to 0 cell counts (either none on ART at enrollment or none who had not initiated by 6 months).